Guangxi Beisheng Pharmaceutical(SSE：600556) loss forecast and trading suspension

According to the Guangxi Beisheng Pharmaceutical Co., Ltd (SSE：600556), the company predicts loss for the year of 2008. Concrete figures will be disclosed in its 2008 annual report. The result of the same period in the previous year is cny -319,119,599.20. If the Company records loss in 2008, The Company’s stocks will be suspended from listing due to three consecutive years of losses in 2006, 2007 and 2008. And due to the restructuring event involved in by the company, trading of the company’s stock will be suspended from December 29, 2008 and resumed upon the approval of the restructuring plan from the court and the Shanghai Stock Exchange. If the company fails to get approval from the court, the company will expose the risk of delisting. The company's board of directors hereby reminded the investors of investment risks.